Inhibitory effects of Triptolide on interferon-γ-induced human leucocyte antigen-DR, intercellular adhesion molecule-1, CD40 expression on retro-ocular fibroblasts derived from patients with Graves' ophthalmopathy

Clinical and Experimental Ophthalmology

Volumn 34, Issue 3, 2006, Pages 265-271

  Yan, Shu Xun ^a   Wang, Ying ^b  

^a HENAN UNIVERSITY OF CHINESE MEDICINE   (China)

^b ZHENGZHOU UNIVERSITY   (China)

Author keywords

CD40; Graves' ophthalmology; HLA DR antigen; Intercellular adhesion molecule 1; Triptolide

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CD40 ANTIGEN; GLUCOCORTICOID; HLA DR ANTIGEN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; RECOMBINANT GAMMA INTERFERON; THYMIDINE; TRIPTOLIDE;

ADULT; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CASE REPORT; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOCRINE OPHTHALMOPATHY; EYE SURGERY; FEMALE; FIBROBLAST CULTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INCUBATION TIME; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RADIOIMMUNOASSAY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SKIN FIBROBLAST; SURGICAL TECHNIQUE; UNSPECIFIED SIDE EFFECT;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD40; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DITERPENES; DNA REPLICATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; FEMALE; FIBROBLASTS; FLOW CYTOMETRY; GRAVES OPHTHALMOPATHY; HLA-DR ANTIGENS; HUMANS; HYALURONIC ACID; IMMUNOSUPPRESSIVE AGENTS; INTERCELLULAR ADHESION MOLECULE-1; INTERFERON-GAMMA, RECOMBINANT; PHENANTHRENES; RADIOIMMUNOASSAY; SKIN; TRIPTERYGIUM;

EID: 33645743816     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2006.01190.x     Document Type: Article

References (23)

1. Wall JR, Salvi M, Bernard NF, Boucher A, Haegert D. Thyroid-associated ophthalmopathy - a model for the association of organ-specific autoimmune disorders. Immunol Today 1991; 12: 150-3.
2. Burch HB, Wartofsky L. Graves' ophthalmopathy: Current concepts regarding pathogenesis and management. Endocr Rev 1993; 14: 747-93.
3. Heufelder AE, Bahn RS. Detection and localization of cytokine immunoreactivity in retroocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest 1993; 23: 10-17.
4. Heufelder AE, Smith TJ, Gorman CA, Bahn RS. Increased induction of HLA-DR by interferon-γ in cultured retroocular fibroblasts derived from patients with Graves' ophthalmopathy and pretibial myxedema. J Clin Endocrinol Metab 1991; 73: 307-13.
5. Hiromatsu Y, Tanka K, Ishisaka N et al. Human histocompatibility leukocyte antigen DR and heat shock protein 70 expressions in eye muscle tissue in thyroid associated ophthalmopathy. J Clin Endocrinol Metab 1995; 80: 685-91.
6. Heufelder AE, Bahn RS. Modulation of intercellular adhesion molecule-1 (ICAM-1) by cytokines and Graves' IgGs in cultured Graves' retroocular fibroblasts. Eur J Clin Invest 1992; 22: 529-37.
7. Cao HJ, Wang H-S, Zhang Y, Lin H-Y, Phipps RP, Smith TJ. Activation of human orbital fibroblasts through CD40 engagement results in a dramaticinduction of hyaluronan synthesis and prostaglandin Endoperoxide H Synthase-2 expression. J Biol Chem 1998; 273: 29615-25.
8. Li LS, Liu ZH. The prospect of Triptergium wilfordii application in the field of nephrology. Chin J Nephrol Dial Transplant 1997; 6: 203-4.
9. Gu WZ, Chen R, Brandwein S, McAlpine J, Burres N. Isolation, purification and characterization of immunosuppressive compounds from tripterygium: Triptolide and tripdiolide. Int J Immunopharmacol 1995; 17: 351-6.
10. Lu H, Hachida M, Enosawa S, Li XK, Suzuki S, Koyanagi H. Immunosuppressive effect of Triptolide in vitro. Transplant Proc 1999; 31: 2056-7.
11. Yang SX, Gao HL, Xie SS, Zhang WR, Long ZZ. Immunosuppression of Triptolide and its effect on skin allograft survival. Int J Immunopharmacol 1992; 14: 963-9.
12. Wang J, Xu R, Jin R, Chen Z, Fidler JM. Immunosuppressive activity of the Chinese medicinal plant Triptergium wilfordii. I. Prolongation of rat cardiac and renal allograft survival by the PG27 extract and immunosuppressive synergy in combination therapy with cyclosporine. Transplantation 2000; 70: 447-55.
13. Yang SX, Xie SS, Gao HL, Ma DL, Long ZZ. Triptolide suppresses T-lymphocyte proliferation by inhibiting interleukin-2 receptor expression, but spares interleukin-2 production and mRNA expression. Int J Immunopharmacol 1994; 16: 895-904.
14. Qiu D, Kao PN. Immunosuppressive and anti-inflammatory mechanisms of Triptolide, the principal active diterpenoid from the Chinese Medicinal Herb Tripterygium wilfordii Hook. f. Drugs R D 2003; 4: 1-18.
15. Yang YL, Liu ZH, Tolosa E, Yang JW, Li LS. Triptolide induced apoptotic death of T lymphocyte. Immunopharmacology 1998; 40: 139-49.
16. Li H, Liu ZH, Dai CS, Liu D, Li LS. Triptolide inhibits proinflammatory factor-induced over-expression of class II MHC and B7 molecules in renal tubular epithelial cells. Acta Pharmacol Sin 2002; 23: 775-81.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
18. Tao XL, Sun Y, Dong Y et al. A prospective, controlled, double blind, cross-over study of tripterygium wilfordii hook F in treatment of rheumatoid arthritis. Chin Med J (Engl) 1989; 102: 327-32.
19. Tao X, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium Wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991; 34: 1274 - 81.
20. Zhao Q, Liu Y, Li Q. The effects of Triptolide on HLA antigens expression of corneal epithelial cells induced by interferon-gamma in vitro. Yan Ke Xue Bao 2000; 16: 34-7.
21. Bretscher P. The two-signal model of lymphocytes activation twenty-one year later. Immunol Today 1992: 381-9.
22. Makgoba MW, Sanders ME, Ginther Luce GE et al. ICAM-1 a ligand for LFA-1-dependent adhesion of B, T and myeloid cells. Nature 1988; 331: 86-8.
23. Sempowski GD, Rozenblit J, Smith TJ, Phipps RP. Human orbital fibroblasts are activated through CD40 to induce proinflammatory cytokine production. Am J Physiol 1998; 274: C707-14.